Bleeding is not the main clinical issue in many patients with inherited thrombocytopaenias

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Haemophilia

• Publication date

  2017-06-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/hae.13255PMID 28594466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inherited platelet dysfunction and hematopoietic transcription factor mutations

  2017cited by this paper
• 5’UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia

  2017cited by this paper
• Inherited thrombocytopenias—recent advances in clinical and molecular aspects

  2017cited by this paper
• CD5-Negative Mantle Cell Leukemia Shows Frequent 17p Deletion and Marrow Involvement Mimicking Marginal Zone Lymphoma

  2016cited by this paper
• SLIT2/ROBO2 signaling pathway inhibits nonmuscle myosin IIA activity and destabilizes kidney podocyte adhesion.

  2016cited by this paper
• How I diagnose and manage individuals at risk for inherited myeloid malignancies.

  2016cited by this paper
• Diagnosis and treatment of inherited thrombocytopenias

  2016cited by this paper
• The E3 ligase Ubr3 regulates Usher syndrome and MYH9 disorder proteins in the auditory organs of Drosophila and mammals

  2016cited by this paper
• The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

  2016cited by this paper
• Hereditary Predispositions to Myelodysplastic Syndrome

  2016cited by this paper
• A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss.

  2016cited by this paper
• Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia

  2016cited by this paper
• Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults

  2016cited by this paper
• Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy

  2015cited by this paper
• Germline Genetic Variation in ETV6 and Risk of Childhood Acute Lymphoblastic Leukemia: a Systematic Genetic Study

  2015cited by this paper
• Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia

  2015cited by this paper
• Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia

  2015cited by this paper
• Mutations in MECOM, Encoding Oncoprotein EVI1, Cause Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia.

  2015cited by this paper
• Spectrum of the Mutations in Bernard–Soulier Syndrome

  2014cited by this paper
• Cochlear implantation is safe and effective in patients with MYH9-related disease

  2014cited by this paper
• Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation.

  2014cited by this paper
• ETV6 mutation in a cohort of 970 patients with hematologic malignancies

  2014cited by this paper
• Reduced intensity transplantation for congenital amegakaryocytic thrombocytopenia: Report of a case and review of the literature

  2014cited by this paper
• MYH9‐Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype–Phenotype Correlations

  2014cited by this paper
• Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders.

  2014cited by this paper
• Lessons in platelet production from inherited thrombocytopenias

  2014cited by this paper
• Wiskott–Aldrich syndrome: diagnosis, current management, and emerging treatments

  2014cited by this paper
• Genomic characterization of the inherited bone marrow failure syndromes.

  2013cited by this paper
• Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling.

  2013cited by this paper
• ANKRD26-related thrombocytopenia and myeloid malignancies.

  2013cited by this paper
• Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia.

  2013cited by this paper
• Inheritance of low-frequency regulatory SNPs and a rare null mutation in exon-junction complex subunit RBM8A causes TAR

  2012cited by this paper
• Myeloid malignancies: mutations, models and management

  2012cited by this paper
• Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation

  2012cited by this paper
• Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome

  2012cited by this paper
• Faculty Opinions recommendation of Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome.

  2012cited by this paper
• Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families.

  2011cited by this paper
• Familial myelodysplastic syndromes: a review of the literature

  2011cited by this paper
• Thrombocytopenia-Absent Radius Syndrome

  2011cited by this paper
• Recent advances in the understanding and management of MYH9‐related inherited thrombocytopenias

  2011cited by this paper
• Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2.

  2011cited by this paper
• Congenital Amegakaryocytic Thrombocytopenia: Clinical Presentation, Diagnosis, and Treatment

  2011cited by this paper
• Heavy chain myosin 9-related disease (MYH9-RD): Neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder

  2010cited by this paper
• Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations.

  2010cited by this paper
• Pathophysiology and management of inherited bone marrow failure syndromes.

  2010cited by this paper
• Advances in the understanding of congenital amegakaryocytic thrombocytopenia

  2009cited by this paper
• Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia

  2009cited by this paper
• Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival.

  2004cited by this paper
• Thrombocytopenia-absent radius syndrome

  2003cited by this paper
• The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications.

  2003cited by this paper
• Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome

  2003cited by this paper
• Acute myeloid leukemia in a patient with thrombocytopenia with absent radii syndrome.

  2002cited by this paper
• In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.

  2002cited by this paper
• Congenital thrombocytopenia and radio‐ulnar synostosis: a new familial syndrome

  2001cited by this paper
• Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome).

  2001cited by this paper
• A novel CBFA2 single-nucleotide mutation in familial platelet disorder with propensity to develop myeloid malignancies.

  2001cited by this paper
• Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium.

  2000cited by this paper
• Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly

  2000cited by this paper
• Late onset bone marrow failure associated with proximal fusion of radius and ulna: a new syndrome

  1989cited by this paper
• The Application of Clinical Genetics Dovepress Wiskott–aldrich Syndrome: Diagnosis, Current Management, and Emerging Treatments

  year unknowncited by this paper

• Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk

  2025cites this paper
• Characterization of Novel Variants in P2YRY12, GP6 and TBXAS1 in Patients with Lifelong History of Bleeding

  2025cites this paper
• Hereditary thrombocytopenias: the challenge of increasing frequency and differential diagnosis

  2025cites this paper
• Screening for gene variants causing inherited platelet disorders: are the cons always cons?

  2024cites this paper
• Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders.

  2023cites this paper
• Learning the Ropes of Platelet Count Regulation: Inherited Thrombocytopenias

  2021cites this paper
• Inherited Platelet Disorders: An Updated Overview

  2021cites this paper
• Diagnosing Inherited Platelet Disorders: Modalities and Consequences

  2021cites this paper
• Blood platelet formation at a glance

  2020cites this paper
• Chronic Thrombocytopenia as the Initial Manifestation of STIM1-Related Disorders

  2020cites this paper
• Long-Lasting Thrombocytopenia and Senile Cataract.

  2020cites this paper
• Population based frequency of naturally occurring loss‐of‐function variants in genes associated with platelet disorders

  2020cites this paper
• Management of inherited thrombocytopenia. Recommendations of the Group on Hemostasis of the Polish Society of Hematology and Transfusion Medicine, 2019

  2020cites this paper
• Inherited thrombocytopenias: an updated guide for clinicians.

  2020cites this paper
• Outcome of an enhanced diagnostic pipeline for patients suspected of inherited thrombocytopenia

  2019cites this paper
• ANKRD26-related thrombocytopenia: case report and literature review of inherited thrombocytopenias with predisposition to malignancies

  2019influential citation
• Mise au point : les thrombopénies constitutionnelles

  2018cites this paper
• Laboratory diagnosis of clinically relevant platelet function disorders

  2018cites this paper
• Inherited Platelet Defects

  2018cites this paper
• ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia

  2018cites this paper
• Extramedullary hematopoiesis: a new feature of inherited thrombocytopenias?

  2017cites this paper